{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:04:34Z","timestamp":1793707474799,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.lfs.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T04:32:17Z","timestamp":1478665937000},"page":"54-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["How much alcohol is in ketamine's antidepressant action?"],"prefix":"10.1016","volume":"168","author":[{"given":"Udo","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.11.003_bb0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2016.11.003_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnana.2013.00023","article-title":"Brain damages in ketamine addicts as revealed by magnetic resonance imaging","volume":"7","author":"Wang","year":"2013","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.lfs.2016.11.003_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/SAR.S15458","article-title":"To use or not to use: an update on licit and illicit ketamine use","volume":"2","author":"Li","year":"2011","journal-title":"Subst. Abuse Rehabil."},{"issue":"Pt 1","key":"10.1016\/j.lfs.2016.11.003_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2016.05.016","article-title":"Ketamine abuse potential and use disorder","volume":"126","author":"Liu","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2016.11.003_bb0025","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","article-title":"Ketamine administration in depressive disorders: a systematic review and meta-analysis","volume":"231","author":"Fond","year":"2014","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.lfs.2016.11.003_bb0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","article-title":"A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action","volume":"156","author":"Naughton","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.lfs.2016.11.003_bb0035","doi-asserted-by":"crossref","DOI":"10.1177\/0004867416631828","article-title":"Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation","author":"Cusin","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.lfs.2016.11.003_bb0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40473-016-0075-4","article-title":"Current trends in identifying rapidly acting treatments for depression","volume":"3","author":"Ionescu","year":"2016","journal-title":"Curr. Behav. Neurosci. Rep."},{"issue":"9","key":"10.1016\/j.lfs.2016.11.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011612.pub2","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","volume":"23","author":"Caddy","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2016.11.003_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12910-016-0087-3","article-title":"Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications","volume":"17","author":"Zhang","year":"2016","journal-title":"BMC Med. Ethics"},{"issue":"3","key":"10.1016\/j.lfs.2016.11.003_bb0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hup.2475","article-title":"The use of ketamine as an antidepressant: a systematic review and meta-analysis","volume":"30","author":"Coyle","year":"2015","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2016.11.003_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/acps.12572","article-title":"Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression","volume":"134","author":"Loo","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"issue":"8","key":"10.1016\/j.lfs.2016.11.003_bb0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.lfs.2016.11.003_bb0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0019-5545.111461","article-title":"Intramuscular ketamine in acute depression. A report on two cases","volume":"55","author":"Harihar","year":"2013","journal-title":"Indian J. Psychiatry"},{"issue":"4","key":"10.1016\/j.lfs.2016.11.003_bb0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/02791072.2015.1072653","article-title":"Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine's antidepressant response and the development of ketamine addiction","volume":"47","author":"Bonnet","year":"2015","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.lfs.2016.11.003_bb0080","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-med-053013-062946","article-title":"Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics","volume":"66","author":"Abdallah","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.lfs.2016.11.003_bb0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pnpbp.2015.06.001","article-title":"Antidepressant drug action \u2014 from rapid changes on network function to network rewiring","volume":"64","author":"Rantam\u00e4ki","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.11.003_bb0090","first-page":"198","article-title":"Striking similarities between clinical and biological properties of ketamine and ethanol: linking antidepressant-after effect and burgeoning addiction?","volume":"3","author":"Bonnet","year":"2015","journal-title":"J. Alcohol. Drug Depend."},{"issue":"1","key":"10.1016\/j.lfs.2016.11.003_bb0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/TP.0000000000000965","article-title":"Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial","volume":"100","author":"Geissler","year":"2016","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.lfs.2016.11.003_bb0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cns.12104","article-title":"Ketamine and peripheral inflammation","volume":"19","author":"De Kock","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2016.11.003_bb0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pnpbp.2015.09.001","article-title":"Opposing effects of alcohol on the immune system","volume":"65","author":"Barr","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.lfs.2016.11.003_bb0110","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/mp.2013.87","article-title":"Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties","volume":"18","author":"Zunszain","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.lfs.2016.11.003_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.alcohol.2014.10.002","article-title":"Acute immunomodulatory effects of binge alcohol ingestion","volume":"49","author":"Afshar","year":"2015","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.lfs.2016.11.003_bb0120","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00429-014-0755-3","article-title":"Structural reorganization of pyramidal neurons in the medial prefrontal cortex of alcohol dependent rats is associated with altered glial plasticity","volume":"220","author":"Kim","year":"2015","journal-title":"Brain Struct. Funct."},{"issue":"4","key":"10.1016\/j.lfs.2016.11.003_bb0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0893-133X(89)90034-1","article-title":"Effects of ethanol on fight- or swim stressed mice in Porsolt's swim test","volume":"2","author":"Hilakivi","year":"1989","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2016.11.003_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2005.11.005","article-title":"Glutamate- and GABA-based CNS therapeutics","volume":"6","author":"Foster","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.lfs.2016.11.003_bb0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbb.2013.10.009","article-title":"The neurobiology of alcohol consumption and alcoholism: an integrative history","volume":"113","author":"Tabakoff","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.lfs.2016.11.003_bb0140","first-page":"273","article-title":"Long term ketamine and ketamine plus alcohol toxicity - what can we learn from animal models?","volume":"13","author":"Wai","year":"2013","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.lfs.2016.11.003_bb0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4103\/0253-7176.135395","article-title":"Ketamine dependence in an anesthesiologist: an occupational hazard?","volume":"36","author":"Goyal","year":"2014","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.lfs.2016.11.003_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ajad.12153","article-title":"Intensive ketamine use for multiple years: a case report","volume":"24","author":"Liu","year":"2015","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.lfs.2016.11.003_bb0155","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/sj.npp.1300994","article-title":"Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism","volume":"31","author":"Krystal","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.lfs.2016.11.003_bb0160","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/npp.2011.20","article-title":"Perturbation of the glutamate-glutamine system in alcohol dependence and remission","volume":"36","author":"Thoma","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2016.11.003_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/B978-0-444-62619-6.00018-5","article-title":"Molecular imaging in alcohol dependence","volume":"125","author":"Ravan","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"8","key":"10.1016\/j.lfs.2016.11.003_bb0170","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.alcohol.2015.09.001","article-title":"Alcohol-induced alterations in dopamine modulation of prefrontal activity","volume":"49","author":"Trantham-Davidson","year":"2015","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.lfs.2016.11.003_bb0175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1523\/JNEUROSCI.2254-15.2016","article-title":"The first alcohol drink triggers mTORC1-dependent synaptic plasticity in nucleus accumbens dopamine D1 receptor neurons","volume":"36","author":"Beckley","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2016.11.003_bb0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(97)00255-2","article-title":"Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex","volume":"759","author":"Lindefors","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2016.11.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043947","article-title":"Chronic ketamine administration modulates midbrain dopamine system in mice","volume":"7","author":"Tan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.11.003_bb0190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-physiol-020911-153315","article-title":"Neurotransmitter corelease: mechanism and physiological role","volume":"74","author":"Hnasko","year":"2012","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.lfs.2016.11.003_bb0195","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12864-016-2713-3","article-title":"Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action","volume":"17","author":"Ficek","year":"2016","journal-title":"BMC Genomics"},{"issue":"21\u201322","key":"10.1016\/j.lfs.2016.11.003_bb0200","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1007\/s00213-015-4022-y","article-title":"Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats","volume":"232","author":"Grimm","year":"2015","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.lfs.2016.11.003_bb0205","doi-asserted-by":"crossref","first-page":"947529","DOI":"10.1155\/2015\/947529","article-title":"Acute effects of alcohol on the human brain: a resting-state FMRI study","volume":"2015","author":"Zheng","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.lfs.2016.11.003_bb0210","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/npp.2014.26","article-title":"Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks","volume":"39","author":"Dawson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2016.11.003_bb0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pscychresns.2016.06.006","article-title":"Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder","volume":"254","author":"Nugent","year":"2016","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.lfs.2016.11.003_bb0220","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.amjmed.2005.01.007","article-title":"The prevalence and impact of alcohol problems in major depression: a systematic review","volume":"118","author":"Sullivan","year":"2005","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.lfs.2016.11.003_bb0225","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1360-0443.2010.03351.x","article-title":"Alcohol and depression","volume":"106","author":"Boden","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.lfs.2016.11.003_bb0230","doi-asserted-by":"crossref","first-page":"858251","DOI":"10.1155\/2015\/858251","article-title":"Lithium and valproate levels do not correlate with ketamine's antidepressant efficacy in treatment-resistant bipolar depression","volume":"2015","author":"Xu","year":"2015","journal-title":"Neural Plast."},{"issue":"3","key":"10.1016\/j.lfs.2016.11.003_bb0235","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/15622975.2016.1142607","article-title":"Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: a pilot randomised controlled trial","volume":"17","author":"Lenze","year":"2016","journal-title":"World J. Biol. Psychiatry"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T22:28:47Z","timestamp":1536272927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516306348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":47,"alternative-id":["S0024320516306348"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.11.003","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How much alcohol is in ketamine's antidepressant action?","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}